Eudaimonia Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$1.07M Sell
3,196
-437
-12% -$134K 0.25% 88
2023
Q4
$983K Buy
3,633
+46
+1% +$11.4K 0.26% 88
2023
Q3
$882K Sell
3,587
-331
-8% -$90.6K 0.21% 105
2023
Q2
$1.19M Sell
3,918
-4
-0.1% -$1.11K 0.27% 93
2023
Q1
$1.03M Hold
3,922
0.25% 102
2022
Q4
$941K Buy
3,922
+52
+1% +$11.6K 0.23% 112
2022
Q3
$711K Sell
3,870
-221
-5% -$44K 0.19% 124
2022
Q2
$688K Buy
4,091
+3,030
+286% +$651K 0.13% 179
2022
Q1
$266K Buy
+1,061
New +$266K 0.05% 331
2021
Q2
Sell
-315
Closed -$59K 774
2021
Q1
$59K Hold
315
0.01% 592
2020
Q4
$52K Buy
315
+50
+19% +$7.31K 0.01% 601
2020
Q3
$33K Buy
+265
New +$32.8K 0.01% 658
2020
Q1
Sell
-203
Closed -$30K 715
2019
Q4
$30K Buy
+203
New +$27.3K 0.01% 603

Other funds holding HCA

Eudaimonia Partners's HCA Position: Q1 2024 in Review

Eudaimonia Partners reduced its HCA Healthcare (HCA) stake by 12% in Q1 2024, selling an estimated $134K and leaving 3,196 shares worth $1.07M. The position accounts for 0.25% of the portfolio, ranked #88.

Eudaimonia Partners first reported a position in HCA in Q4 2019 and has held it in 13 quarters since. The position peaked at $1.19M in Q2 2023. 1,126 funds tracked by Wall St. Rank hold HCA as of Q1 2024.

  • Eudaimonia Partners held 3,196 shares of HCA Healthcare worth $1.07M as of Q1 2024.
  • Eudaimonia Partners sold 437 HCA Healthcare shares in Q1 2024, an estimated $134K.
  • HCA Healthcare made up 0.25% of Eudaimonia Partners's portfolio in Q1 2024, its #88 holding.
  • Eudaimonia Partners first reported a position in HCA Healthcare in Q4 2019 and has held it in 13 quarters since.
  • Eudaimonia Partners's HCA Healthcare position peaked at $1.19M in Q2 2023.
  • 1,126 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.